相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial
A. De Bruycker et al.
BMC CANCER (2020)
Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data
Claire L. Vale et al.
LANCET (2020)
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial
Christopher C. Parker et al.
LANCET (2020)
Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial
Andrew Kneebone et al.
LANCET ONCOLOGY (2020)
Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial
Paul Sargos et al.
LANCET ONCOLOGY (2020)
Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row
Andrei Fodor et al.
WORLD JOURNAL OF UROLOGY (2019)
Adjuvant and Salvage Radiation Therapy After Prostatectomy: ASTRO/AUA Guideline Amendment, Executive Summary 2018
Thomas M. Pisansky et al.
PRACTICAL RADIATION ONCOLOGY (2019)
5-Year Outcomes of a Prospective Phase 1/2 Study of Accelerated Hypofractionated Radiation Therapy to the Prostate Bed
Kevin Martell et al.
PRACTICAL RADIATION ONCOLOGY (2019)
Hypofractionated radiotherapy for prostate cancer in the postoperative setting: What is the evidence so far?
Cristina Picardi et al.
CANCER TREATMENT REVIEWS (2018)
Postoperative Radiation Therapy for Prostate Cancer: Comparison of Conventional Versus Hypofractionated Radiation Regimens
Daniel J. Tandberg et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial
Piet Ost et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies
C. M. van Leeuwen et al.
RADIATION ONCOLOGY (2018)
Moderate hypofractionated radiotherapy after prostatectomy for cancer patients: toxicity and clinical outcome
Salvina Barra et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Acute toxicity profiles of hypofractionated adjuvant and salvage radiotherapy after radical prostatectomy: results of a prospective study
Simonetta Saldi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Hypofractionated postoperative helical tomotherapy in prostate cancer: a mono-institutional report of toxicity and clinical outcomes
Francesco Cuccia et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based Guideline
Scott C. Morgan et al.
PRACTICAL RADIATION ONCOLOGY (2018)
Post-prostatectomy radiation therapy for locally recurrent prostate cancer
Sudhir Isharwal et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2017)
Conventional Versus Hypofractionated Radiation Therapy for Localized or Locally Advanced Prostate Cancer: A Systematic Review and Meta-analysis along with Therapeutic Implications
Niloy R. Datta et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Exploring All Avenues for Radiotherapy in Oligorecurrent Prostate Cancer Disease Limited to Lymph Nodes: A Systematic Review of the Role of Stereotactic Body Radiotherapy
Elisabetta Ponti et al.
EUROPEAN UROLOGY FOCUS (2017)
Hypofractionated Postoperative IMRT in Prostate Carcinoma: A Phase I/II Study
Gabriella Macchia et al.
ANTICANCER RESEARCH (2017)
Moderate Hypofractionated Postprostatectomy Volumetric Modulated Arc Therapy With Daily Image Guidance (VMAT-IGRT): A Mono-institutional Report on Feasibility and Acute Toxicity
Sergio Fersino et al.
CLINICAL GENITOURINARY CANCER (2017)
Image Guided Hypofractionated Postprostatectomy Intensity Modulated Radiation Therapy for Prostate Cancer
Stephen L. Lewis et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
The Effectiveness of Intensity Modulated Radiation Therapy versus Three-Dimensional Radiation Therapy in Prostate Cancer: A Meta-Analysis of the Literatures
Ting Yu et al.
PLOS ONE (2016)
Metastasis-directed Therapy of Regional and Distant Recurrences After Curative Treatment of Prostate Cancer: A Systematic Review of the Literature
Piet Ost et al.
EUROPEAN UROLOGY (2015)
Management of Node Only Recurrence after Primary Local Treatment for Prostate Cancer: A Systematic Review of the Literature
Guillaume Ploussard et al.
JOURNAL OF UROLOGY (2015)
Higher-than-expected Severe (Grade 3-4) Late Urinary Toxicity After Postprostatectomy Hypofractionated Radiotherapy: A Single-institution Analysis of 1176 Patients
Cesare Cozzarini et al.
EUROPEAN UROLOGY (2014)
Hypofractionated IMRT of the Prostate Bed After Radical Prostatectomy: Acute Toxicity in the PRIAMOS-1 Trial
Sonja Katayama et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
192 The 10-years follow-up of the ARO 96-02/AUO AP 09/95 trial on adjuvant radiotherapy (ART) versus wait-and-see (WS) after prostatectomy for pT3 cancer – subgroup analysis
T. Wiegel et al.
EUROPEAN UROLOGY SUPPLEMENTS (2013)
Adjuvant and Salvage Radiation Therapy After Prostatectomy: American Society for Radiation Oncology/American Urological Association Guidelines
Richard K. Valicenti et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial
Edy Ippolito et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Postoperative Radiation Therapy for Pathologically Advanced Prostate Cancer After Radical Prostatectomy
Andrew J. Stephenson et al.
EUROPEAN UROLOGY (2012)
Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)
Michel Bolla et al.
LANCET (2012)
Early Hypofractionated Salvage Radiotherapy for Postprostatectomy Biochemical Recurrence
Tim J. Kruser et al.
CANCER (2011)
DEVELOPMENT OF RTOG CONSENSUS GUIDELINES FOR THE DEFINITION OF THE CLINICAL TARGET VOLUME FOR POSTOPERATIVE CONFORMAL RADIATION THERAPY FOR PROSTATE CANCER
Jeff M. Michalski et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy
Gordon W. Wong et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Pathologic findings at radical prostatectomy: Risk factors for failure and death
Gregory P. Swanson et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2007)
The radiobiology of prostate cancer including new aspects of fractionatedradiotherapy
JF Fowler
ACTA ONCOLOGICA (2005)
A simple analytic derivation suggests that prostate cancer α/β ratio is low
CR King et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
Is α/β for prostate tumors really low?
J Fowler et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
分享论文
